Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

Abstract An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and...

Full description

Bibliographic Details
Main Authors: Delores J. Grant, Ani Manichaikul, Anthony J. Alberg, Elisa V. Bandera, Jill Barnholtz‐Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, Patricia G. Moorman, Lauren C. Peres, Edward S. Peters, Ann G. Schwartz, Paul D. Terry, Xin‐Qun Wang, Temitope O. Keku, Cathrine Hoyo, Andrew Berchuck, Dale P. Sandler, Jack A. Taylor, Katie M. O’Brien, Digna R. Velez Edwards, Todd L. Edwards, Alicia Beeghly‐Fadiel, Nicolas Wentzensen, Celeste Leigh Pearce, Anna H. Wu, Alice S. Whittemore, Valerie McGuire, Weiva Sieh, Joseph H. Rothstein, Francesmary Modugno, Roberta Ness, Kirsten Moysich, Mary Anne Rossing, Jennifer A. Doherty, Thomas A. Sellers, Jennifer B. Permuth‐Way, Alvaro N. Monteiro, Douglas A. Levine, Veronica Wendy Setiawan, Christopher A. Haiman, Loic LeMarchand, Lynne R. Wilkens, Beth Y. Karlan, Usha Menon, Susan Ramus, Simon Gayther, Aleksandra Gentry‐Maharaj, Kathryn L. Terry, Daniel W. Cramer, Ellen L. Goode, Melissa C. Larson, Scott H. Kaufmann, Rikki Cannioto, Kunle Odunsi, John L. Etter, Ruea‐Yea Huang, Marcus Q. Bernardini, Alicia A. Tone, Taymaa May, Marc T. Goodman, Pamela J. Thompson, Michael E. Carney, Shelley S. Tworoger, Elizabeth M. Poole, Diether Lambrechts, Ignace Vergote, Adriaan Vanderstichele, Els Van Nieuwenhuysen, Hoda Anton‐Culver, Argyrios Ziogas, James D. Brenton, Line Bjorge, Helga B. Salvensen, Lambertus A. Kiemeney, Leon F. A. G. Massuger, Tanja Pejovic, Amanda Bruegl, Melissa Moffitt, Linda Cook, Nhu D. Le, Angela Brooks‐Wilson, Linda E. Kelemen, Paul D.P. Pharoah, Honglin Song, Ian Campbell, Diana Eccles, Anna DeFazio, Catherine J. Kennedy, Joellen M. Schildkraut
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1996
_version_ 1797236893269622784
author Delores J. Grant
Ani Manichaikul
Anthony J. Alberg
Elisa V. Bandera
Jill Barnholtz‐Sloan
Melissa Bondy
Michele L. Cote
Ellen Funkhouser
Patricia G. Moorman
Lauren C. Peres
Edward S. Peters
Ann G. Schwartz
Paul D. Terry
Xin‐Qun Wang
Temitope O. Keku
Cathrine Hoyo
Andrew Berchuck
Dale P. Sandler
Jack A. Taylor
Katie M. O’Brien
Digna R. Velez Edwards
Todd L. Edwards
Alicia Beeghly‐Fadiel
Nicolas Wentzensen
Celeste Leigh Pearce
Anna H. Wu
Alice S. Whittemore
Valerie McGuire
Weiva Sieh
Joseph H. Rothstein
Francesmary Modugno
Roberta Ness
Kirsten Moysich
Mary Anne Rossing
Jennifer A. Doherty
Thomas A. Sellers
Jennifer B. Permuth‐Way
Alvaro N. Monteiro
Douglas A. Levine
Veronica Wendy Setiawan
Christopher A. Haiman
Loic LeMarchand
Lynne R. Wilkens
Beth Y. Karlan
Usha Menon
Susan Ramus
Simon Gayther
Aleksandra Gentry‐Maharaj
Kathryn L. Terry
Daniel W. Cramer
Ellen L. Goode
Melissa C. Larson
Scott H. Kaufmann
Rikki Cannioto
Kunle Odunsi
John L. Etter
Ruea‐Yea Huang
Marcus Q. Bernardini
Alicia A. Tone
Taymaa May
Marc T. Goodman
Pamela J. Thompson
Michael E. Carney
Shelley S. Tworoger
Elizabeth M. Poole
Diether Lambrechts
Ignace Vergote
Adriaan Vanderstichele
Els Van Nieuwenhuysen
Hoda Anton‐Culver
Argyrios Ziogas
James D. Brenton
Line Bjorge
Helga B. Salvensen
Lambertus A. Kiemeney
Leon F. A. G. Massuger
Tanja Pejovic
Amanda Bruegl
Melissa Moffitt
Linda Cook
Nhu D. Le
Angela Brooks‐Wilson
Linda E. Kelemen
Paul D.P. Pharoah
Honglin Song
Ian Campbell
Diana Eccles
Anna DeFazio
Catherine J. Kennedy
Joellen M. Schildkraut
author_facet Delores J. Grant
Ani Manichaikul
Anthony J. Alberg
Elisa V. Bandera
Jill Barnholtz‐Sloan
Melissa Bondy
Michele L. Cote
Ellen Funkhouser
Patricia G. Moorman
Lauren C. Peres
Edward S. Peters
Ann G. Schwartz
Paul D. Terry
Xin‐Qun Wang
Temitope O. Keku
Cathrine Hoyo
Andrew Berchuck
Dale P. Sandler
Jack A. Taylor
Katie M. O’Brien
Digna R. Velez Edwards
Todd L. Edwards
Alicia Beeghly‐Fadiel
Nicolas Wentzensen
Celeste Leigh Pearce
Anna H. Wu
Alice S. Whittemore
Valerie McGuire
Weiva Sieh
Joseph H. Rothstein
Francesmary Modugno
Roberta Ness
Kirsten Moysich
Mary Anne Rossing
Jennifer A. Doherty
Thomas A. Sellers
Jennifer B. Permuth‐Way
Alvaro N. Monteiro
Douglas A. Levine
Veronica Wendy Setiawan
Christopher A. Haiman
Loic LeMarchand
Lynne R. Wilkens
Beth Y. Karlan
Usha Menon
Susan Ramus
Simon Gayther
Aleksandra Gentry‐Maharaj
Kathryn L. Terry
Daniel W. Cramer
Ellen L. Goode
Melissa C. Larson
Scott H. Kaufmann
Rikki Cannioto
Kunle Odunsi
John L. Etter
Ruea‐Yea Huang
Marcus Q. Bernardini
Alicia A. Tone
Taymaa May
Marc T. Goodman
Pamela J. Thompson
Michael E. Carney
Shelley S. Tworoger
Elizabeth M. Poole
Diether Lambrechts
Ignace Vergote
Adriaan Vanderstichele
Els Van Nieuwenhuysen
Hoda Anton‐Culver
Argyrios Ziogas
James D. Brenton
Line Bjorge
Helga B. Salvensen
Lambertus A. Kiemeney
Leon F. A. G. Massuger
Tanja Pejovic
Amanda Bruegl
Melissa Moffitt
Linda Cook
Nhu D. Le
Angela Brooks‐Wilson
Linda E. Kelemen
Paul D.P. Pharoah
Honglin Song
Ian Campbell
Diana Eccles
Anna DeFazio
Catherine J. Kennedy
Joellen M. Schildkraut
author_sort Delores J. Grant
collection DOAJ
description Abstract An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom‐designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high‐grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significance of selected SNPs using the Bayesian False Discovery Probability (BFDP). A significant association with EOC was identified in the UGT2A1/2 region for the SNP rs10017134 (per allele OR = 1.4, 95% CI = 1.2‐1.7, P = 1.2 × 10−6, BFDP = 0.02); and an association with HGSOC was identified in the EGFR region for the SNP rs114972508 (per allele OR = 2.3, 95% CI = 1.6‐3.4, P = 1.6 × 10−5, BFDP = 0.29) and in the UGT2A1/2 region again for rs1017134 (per allele OR = 1.4, 95% CI = 1.2‐1.7, P = 2.3 × 10−5, BFDP = 0.23). Genetic variants in the EGFR and UGT2A1/2 may increase susceptibility of EOC in AA women. Future studies to validate these findings are warranted. Alterations in EGFR and UGT2A1/2 could perturb enzyme efficacy, proliferation in ovaries, impact and mark susceptibility to EOC.
first_indexed 2024-04-24T17:11:05Z
format Article
id doaj.art-e1138d0ca72749ca892bbfadf3342940
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-24T17:11:05Z
publishDate 2019-05-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-e1138d0ca72749ca892bbfadf33429402024-03-28T10:30:36ZengWileyCancer Medicine2045-76342019-05-01852503251310.1002/cam4.1996Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J. Grant0Ani Manichaikul1Anthony J. Alberg2Elisa V. Bandera3Jill Barnholtz‐Sloan4Melissa Bondy5Michele L. Cote6Ellen Funkhouser7Patricia G. Moorman8Lauren C. Peres9Edward S. Peters10Ann G. Schwartz11Paul D. Terry12Xin‐Qun Wang13Temitope O. Keku14Cathrine Hoyo15Andrew Berchuck16Dale P. Sandler17Jack A. Taylor18Katie M. O’Brien19Digna R. Velez Edwards20Todd L. Edwards21Alicia Beeghly‐Fadiel22Nicolas Wentzensen23Celeste Leigh Pearce24Anna H. Wu25Alice S. Whittemore26Valerie McGuire27Weiva Sieh28Joseph H. Rothstein29Francesmary Modugno30Roberta Ness31Kirsten Moysich32Mary Anne Rossing33Jennifer A. Doherty34Thomas A. Sellers35Jennifer B. Permuth‐Way36Alvaro N. Monteiro37Douglas A. Levine38Veronica Wendy Setiawan39Christopher A. Haiman40Loic LeMarchand41Lynne R. Wilkens42Beth Y. Karlan43Usha Menon44Susan Ramus45Simon Gayther46Aleksandra Gentry‐Maharaj47Kathryn L. Terry48Daniel W. Cramer49Ellen L. Goode50Melissa C. Larson51Scott H. Kaufmann52Rikki Cannioto53Kunle Odunsi54John L. Etter55Ruea‐Yea Huang56Marcus Q. Bernardini57Alicia A. Tone58Taymaa May59Marc T. Goodman60Pamela J. Thompson61Michael E. Carney62Shelley S. Tworoger63Elizabeth M. Poole64Diether Lambrechts65Ignace Vergote66Adriaan Vanderstichele67Els Van Nieuwenhuysen68Hoda Anton‐Culver69Argyrios Ziogas70James D. Brenton71Line Bjorge72Helga B. Salvensen73Lambertus A. Kiemeney74Leon F. A. G. Massuger75Tanja Pejovic76Amanda Bruegl77Melissa Moffitt78Linda Cook79Nhu D. Le80Angela Brooks‐Wilson81Linda E. Kelemen82Paul D.P. Pharoah83Honglin Song84Ian Campbell85Diana Eccles86Anna DeFazio87Catherine J. Kennedy88Joellen M. Schildkraut89Department of Biological and Biomedical Sciences, Cancer Research Program JLC‐Biomedical/Biotechnology Research Institute, North Carolina Central University Durham North CarolinaCenter for Public Health Genomics University of Virginia Charlottesville VirginiaDepartment of Epidemiology and Biostatistics, Arnold School of Public Health University of South Carolina Columbia South CarolinaDepartment of Population Science Rutgers Cancer Institute of New Jersey New Brunswick New JerseyCase Comprehensive Cancer Center Case Western Reserve University School of Medicine Cleveland OhioCancer Prevention and Population Sciences Program Baylor College of Medicine Houston TexasDepartment of Oncology and the Karmanos Cancer Institute Population Studies and Disparities Research Program Wayne State University School of Medicine Detroit MichiganDivision of Preventive Medicine University of Alabama at Birmingham Birmingham AlabamaDepartment of Community and Family Medicine Duke University Medical Center Durham North CarolinaCenter for Public Health Genomics University of Virginia Charlottesville VirginiaEpidemiology Program Louisiana State University Health Sciences Center School of Public Health New Orleans LouisisanaDepartment of Oncology and the Karmanos Cancer Institute Population Studies and Disparities Research Program Wayne State University School of Medicine Detroit MichiganDepartment of Medicine University of Tennessee Medical Center – Knoxville Knoxville TennesseeDepartment of Public Health Sciences University of Virginia Charlottesville VirginiaDepartments of Medicine and Nutrition, Division of Gastroenterology and Hepatology University of North Carolina at Chapel Hill Chapel Hill North CarolinaDepartment of Biological Sciences North Carolina State University Raleigh North CarolinaDepartment of Obstetrics and Gynecology Duke University Medical Center Durham North CarolinaEpidemiology Branch, Division of Intramural Research National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North CarolinaEpidemiology Branch, Division of Intramural Research National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North CarolinaEpidemiology Branch, Division of Intramural Research National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North CarolinaVanderbilt Epidemiology Center, Center for Human Genetics Research, Department of Obstetrics and Gynecology Vanderbilt University Medical Center Nashville TennesseeDivision of Epidemiology, Center for Human Genetics Research, Department of Medicine Vanderbilt University Medical Center Nashville TennesseeDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center Institute for Medicine and Public Health, Vanderbilt University Medical Center Nashville TennesseeDivision of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MarylandDepartment of Epidemiology University of Michigan School of Public Health Ann Arbor MichiganDepartment of Preventive Medicine, Keck School of Medicine University of Southern California Norris Comprehensive Cancer Center Los Angeles CaliforniaDepartment of Health Research and Policy Stanford University School of Medicine Stanford CaliforniaDepartment of Health Research and Policy Stanford University School of Medicine Stanford CaliforniaDepartment of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New YorkDepartment of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New YorkDivision of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh School of Medicine Pittsburgh PennsylvaniaThe University of Texas School of Public Health Houston TexasDepartment of Cancer Prevention and Control Roswell Park Cancer Institute Buffalo New YorkProgram in Epidemiology, Division of Public Health Sciences Fred Hutchinson Cancer Research Center Seattle WashingtonDepartment of Population Health Sciences Huntsman Cancer Institute, University of Utah Salt Lake City, UtahDepartment of Cancer Epidemiology Moffitt Cancer Center Tampa FloridaDepartment of Cancer Epidemiology Moffitt Cancer Center Tampa FloridaDepartment of Cancer Epidemiology Moffitt Cancer Center Tampa FloridaGynecology Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New YorkUniversity of Southern California Norris Comprehensive Cancer Center Los Angeles CaliforniaUniversity of Southern California Norris Comprehensive Cancer Center Los Angeles CaliforniaUniversity of Hawaii Cancer Center Honolulu HawaiiCancer Epidemiology Program University of Hawaii Cancer Center HawaiiWomen's Cancer Program Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center Los Angeles CaliforniaMRC CTU at UCL, Institute of Clinical Trials and Methodology University College London London UKSchool of Women's and Children's Health University of New South Wales New South Wales AustraliaCenter for Cancer Prevention and Translational Genomics Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center Los Angeles CaliforniaMRC CTU at UCL, Institute of Clinical Trials and Methodology University College London London UKObstetrics and Gynecology Epidemiology Center Brigham and Women's Hospital Boston MassachusettsObstetrics and Gynecology Epidemiology Center Brigham and Women's Hospital Boston MassachusettsDepartment of Health Science Research, Division of Epidemiology Mayo Clinic Rochester MinnesotaDepartment of Health Science Research, Division of Biomedical Statistics and Informatics Mayo Clinic Rochester MinnesotaDepartments of Medicine and Pharmacology Mayo Clinic Rochester MinnesotaCancer Pathology & Prevention, Division of Cancer Prevention and Population Sciences Roswell Park Cancer Institute Buffalo New YorkDepartment of Gynecological Oncology Roswell Park Cancer Institute Buffalo New YorkDepartment of Cancer Prevention and Control Roswell Park Cancer Institute Buffalo New YorkCenter For Immunotherapy Roswell Park Cancer Institute Buffalo New YorkDivision of Gynecologic Oncology Princess Margaret Hospital, University Health Network Toronto Ontario CanadaDivision of Gynecologic Oncology Princess Margaret Hospital, University Health Network Toronto Ontario CanadaDivision of Gynecologic Oncology Princess Margaret Hospital, University Health Network Toronto Ontario CanadaCancer Prevention and Control Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center Los Angeles CaliforniaCancer Prevention and Control Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center Los Angeles CaliforniaDepartment of Obstetrics and Gynecology John A. Burns School of Medicine, University of Hawaii Honolulu HawaiiChanning Division of Network Medicine Brigham and Women's Hospital and Harvard Medical School Boston MassachusettsBiostatistics, Sanofi Genzyme Boston MassachusettsVesalius Research Center, VIB Leuven BelgiumDivision of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute University Hospitals Leuven Leuven BelgiumDivision of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute University Hospitals Leuven Leuven BelgiumDivision of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute University Hospitals Leuven Leuven BelgiumDepartment of Epidemiology, Director of Genetic Epidemiology Research Institute, Center for Cancer Genetics Research & Prevention, School of Medicine University of California Irvine Irvine CaliforniaDepartment of Epidemiology University of California Irvine Irvine CaliforniaCancer Research UK Cambridge Institute University of Cambridge Cambridge UKDepartment of Gynecology and Obstetrics Haukeland University Hospital Bergen NorwayDepartment of Gynecology and Obstetrics Haukeland University Hospital Bergen NorwayRadboud University Medical Center Radboud Institute for Health Sciences Nijmegen NetherlandsDepartment of Gynaecology, Radboud University Medical Center Radboud Institute for Molecular Life sciences Nijmegen The NetherlandsDepartment of Obstetrics & Gynecology Oregon Health & Science University Portland OregonDepartment of Obstetrics & Gynecology Oregon Health & Science University Portland OregonDepartment of Obstetrics & Gynecology Oregon Health & Science University Portland OregonDivision of Epidemiology and Biostatistics, Department of Internal Medicine University of New Mexico Albuquerque New MexicoCancer Control Research, British Columbia Cancer Agency Vancouver British Columbia CanadaCanada's Michael Smith Genome Sciences Centre British Columbia Cancer Agency Vancouver British Columbia CanadaHollings Cancer Center and Department of Public Health Sciences Medical University of South Carolina Charleston South CarolinaStrangeways Research laboratory, Department of Oncology, Department of Public Health and Primary Care University of Cambridge Cambridge UKStrangeways Research Laboratory, Department of Oncology University of Cambridge Cambridge UKCancer Genetics Laboratory, Research Division Peter MacCallum Cancer Centre Victoria AustraliaFaculty of Medicine University of Southampton Southampton UKCentre for Cancer Research The Westmead Institute for Medical Research, The University of Sydney Sydney New South Wales AustraliaCentre for Cancer Research The Westmead Institute for Medical Research, The University of Sydney Sydney New South Wales AustraliaDepartment of Public Health Sciences University of Virginia Charlottesville VirginiaAbstract An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom‐designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high‐grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significance of selected SNPs using the Bayesian False Discovery Probability (BFDP). A significant association with EOC was identified in the UGT2A1/2 region for the SNP rs10017134 (per allele OR = 1.4, 95% CI = 1.2‐1.7, P = 1.2 × 10−6, BFDP = 0.02); and an association with HGSOC was identified in the EGFR region for the SNP rs114972508 (per allele OR = 2.3, 95% CI = 1.6‐3.4, P = 1.6 × 10−5, BFDP = 0.29) and in the UGT2A1/2 region again for rs1017134 (per allele OR = 1.4, 95% CI = 1.2‐1.7, P = 2.3 × 10−5, BFDP = 0.23). Genetic variants in the EGFR and UGT2A1/2 may increase susceptibility of EOC in AA women. Future studies to validate these findings are warranted. Alterations in EGFR and UGT2A1/2 could perturb enzyme efficacy, proliferation in ovaries, impact and mark susceptibility to EOC.https://doi.org/10.1002/cam4.1996African ancestry riskgenetic associationovarian cancervitamin D pathway
spellingShingle Delores J. Grant
Ani Manichaikul
Anthony J. Alberg
Elisa V. Bandera
Jill Barnholtz‐Sloan
Melissa Bondy
Michele L. Cote
Ellen Funkhouser
Patricia G. Moorman
Lauren C. Peres
Edward S. Peters
Ann G. Schwartz
Paul D. Terry
Xin‐Qun Wang
Temitope O. Keku
Cathrine Hoyo
Andrew Berchuck
Dale P. Sandler
Jack A. Taylor
Katie M. O’Brien
Digna R. Velez Edwards
Todd L. Edwards
Alicia Beeghly‐Fadiel
Nicolas Wentzensen
Celeste Leigh Pearce
Anna H. Wu
Alice S. Whittemore
Valerie McGuire
Weiva Sieh
Joseph H. Rothstein
Francesmary Modugno
Roberta Ness
Kirsten Moysich
Mary Anne Rossing
Jennifer A. Doherty
Thomas A. Sellers
Jennifer B. Permuth‐Way
Alvaro N. Monteiro
Douglas A. Levine
Veronica Wendy Setiawan
Christopher A. Haiman
Loic LeMarchand
Lynne R. Wilkens
Beth Y. Karlan
Usha Menon
Susan Ramus
Simon Gayther
Aleksandra Gentry‐Maharaj
Kathryn L. Terry
Daniel W. Cramer
Ellen L. Goode
Melissa C. Larson
Scott H. Kaufmann
Rikki Cannioto
Kunle Odunsi
John L. Etter
Ruea‐Yea Huang
Marcus Q. Bernardini
Alicia A. Tone
Taymaa May
Marc T. Goodman
Pamela J. Thompson
Michael E. Carney
Shelley S. Tworoger
Elizabeth M. Poole
Diether Lambrechts
Ignace Vergote
Adriaan Vanderstichele
Els Van Nieuwenhuysen
Hoda Anton‐Culver
Argyrios Ziogas
James D. Brenton
Line Bjorge
Helga B. Salvensen
Lambertus A. Kiemeney
Leon F. A. G. Massuger
Tanja Pejovic
Amanda Bruegl
Melissa Moffitt
Linda Cook
Nhu D. Le
Angela Brooks‐Wilson
Linda E. Kelemen
Paul D.P. Pharoah
Honglin Song
Ian Campbell
Diana Eccles
Anna DeFazio
Catherine J. Kennedy
Joellen M. Schildkraut
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
Cancer Medicine
African ancestry risk
genetic association
ovarian cancer
vitamin D pathway
title Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
title_full Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
title_fullStr Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
title_full_unstemmed Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
title_short Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
title_sort evaluation of vitamin d biosynthesis and pathway target genes reveals ugt2a1 2 and egfr polymorphisms associated with epithelial ovarian cancer in african american women
topic African ancestry risk
genetic association
ovarian cancer
vitamin D pathway
url https://doi.org/10.1002/cam4.1996
work_keys_str_mv AT deloresjgrant evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT animanichaikul evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT anthonyjalberg evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT elisavbandera evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT jillbarnholtzsloan evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT melissabondy evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT michelelcote evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT ellenfunkhouser evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT patriciagmoorman evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT laurencperes evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT edwardspeters evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT anngschwartz evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT pauldterry evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT xinqunwang evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT temitopeokeku evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT cathrinehoyo evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT andrewberchuck evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT dalepsandler evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT jackataylor evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT katiemobrien evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT dignarvelezedwards evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT toddledwards evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT aliciabeeghlyfadiel evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT nicolaswentzensen evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT celesteleighpearce evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT annahwu evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT aliceswhittemore evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT valeriemcguire evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT weivasieh evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT josephhrothstein evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT francesmarymodugno evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT robertaness evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT kirstenmoysich evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT maryannerossing evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT jenniferadoherty evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT thomasasellers evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT jenniferbpermuthway evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT alvaronmonteiro evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT douglasalevine evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT veronicawendysetiawan evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT christopherahaiman evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT loiclemarchand evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT lynnerwilkens evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT bethykarlan evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT ushamenon evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT susanramus evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT simongayther evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT aleksandragentrymaharaj evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT kathrynlterry evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT danielwcramer evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT ellenlgoode evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT melissaclarson evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT scotthkaufmann evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT rikkicannioto evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT kunleodunsi evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT johnletter evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT rueayeahuang evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT marcusqbernardini evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT aliciaatone evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT taymaamay evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT marctgoodman evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT pamelajthompson evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT michaelecarney evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT shelleystworoger evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT elizabethmpoole evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT dietherlambrechts evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT ignacevergote evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT adriaanvanderstichele evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT elsvannieuwenhuysen evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT hodaantonculver evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT argyriosziogas evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT jamesdbrenton evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT linebjorge evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT helgabsalvensen evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT lambertusakiemeney evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT leonfagmassuger evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT tanjapejovic evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT amandabruegl evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT melissamoffitt evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT lindacook evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT nhudle evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT angelabrookswilson evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT lindaekelemen evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT pauldppharoah evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT honglinsong evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT iancampbell evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT dianaeccles evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT annadefazio evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT catherinejkennedy evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen
AT joellenmschildkraut evaluationofvitamindbiosynthesisandpathwaytargetgenesrevealsugt2a12andegfrpolymorphismsassociatedwithepithelialovariancancerinafricanamericanwomen